Candriam Equities L Biotech.C EUR/ LU1120766388 /
| NAV2024-05-06 | Chg.-0.4800 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 217.9100EUR | -0.22% | reinvestment | Equity Worldwide | Candriam ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015 | - | - | - | - | - | -0.99 | 5.05 | -12.19 | -11.06 | 8.94 | 8.18 | -2.47 | - |
| 2016 | -22.94 | -4.98 | -1.15 | 3.16 | 8.63 | -8.23 | 11.81 | -2.00 | 3.03 | -10.54 | 12.73 | -2.27 | -17.18% |
| 2017 | 2.97 | 8.66 | -0.57 | -0.74 | -6.02 | 7.82 | -0.95 | 5.93 | 1.46 | -5.24 | -2.17 | 0.73 | +11.22% |
| 2018 | 2.84 | -2.57 | -2.96 | -1.49 | 8.26 | 0.77 | 4.17 | 4.70 | -1.93 | -11.86 | 4.19 | -9.20 | -6.81% |
| 2019 | 12.70 | 4.36 | 0.82 | -4.77 | -3.93 | 7.06 | 0.91 | - | - | - | - | - | - |
| 2021 | - | - | - | - | - | - | 31.91 | 4.35 | -2.47 | 0.30 | -1.70 | 1.34 | - |
| 2022 | -9.30 | -1.76 | 7.03 | -2.16 | -5.45 | 6.05 | 7.35 | 2.94 | 0.68 | 5.55 | 1.91 | -6.30 | +4.91% |
| 2023 | 1.12 | -3.40 | -2.17 | 0.63 | 2.56 | -0.90 | -1.63 | 1.34 | -2.10 | -5.97 | 2.83 | 12.21 | +3.49% |
| 2024 | 3.19 | 1.72 | 0.15 | -5.32 | 3.22 | - | - | - | - | - | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 16.56% | 17.91% | 16.12% | 21.54% | 21.49% |
| Sharpe ratio | 0.26 | 1.66 | 0.27 | - | 0.23 |
| Best month | +12.21% | +12.21% | +12.21% | +12.21% | +31.91% |
| Worst month | -5.32% | -5.32% | -5.97% | -9.30% | -9.30% |
| Maximum loss | -9.57% | -9.57% | -14.01% | -19.84% | -19.84% |
| Outperformance | -3.05% | - | -1.13% | +0.44% | - |
All quotes in EUR
Tranches
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Candriam Equities L Biotechnolog... | reinvestment | 2,029.8000 | +6.59% | +11.15% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 217.9100 | +8.11% | - | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,033.9200 | +4.23% | +3.37% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,196.0300 | +8.81% | +23.94% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,385.7500 | +6.92% | +21.04% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 355.4300 | +7.23% | +24.92% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 321.4000 | +9.11% | +26.55% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 198.4700 | +2.07% | +1.87% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,816.8101 | +7.06% | +13.98% | |
| Candriam Equities L Biotech.N-H ... | reinvestment | 147.4000 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 591.0900 | +5.48% | +8.99% | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,559.2402 | +7.40% | +6.35% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 194.6900 | +3.64% | +2.99% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 202.9400 | +4.52% | +5.53% | |
| Candriam Equities L Biotech.R US... | reinvestment | 263.6000 | +7.71% | +8.62% | |
| Candriam Equities L Biotechnolo... | reinvestment | 829.5800 | +5.87% | +10.37% | |
| Candriam Equities L Biotechnolog... | paying dividend | 757.6500 | +5.84% | +10.27% |
Performance
| YTD | +2.73% | ||
|---|---|---|---|
| 6 Months | +15.44% | ||
| 1 Year | +8.11% | ||
| 3 Years | - | ||
| 5 Years | +52.36% | ||
| Since start | +45.27% | ||
| Year | |||
| 2023 | +3.49% | ||
| 2022 | +4.91% | ||
| 2018 | -6.81% | ||
| 2017 | +11.22% | ||
| 2016 | -17.18% | ||
